Literature DB >> 10078593

Expression of the E2 envelope glycoprotein of bovine viral diarrhoea virus (BVDV) elicits virus-type specific neutralising antibodies.

R L Toth1, P F Nettleton, M A McCrae.   

Abstract

A region of genome from the NADL strain of BVDV corresponding to the coding sequence for the E2 glycoprotein has been molecularly cloned using RT-PCR. The viral cDNA sequence was used to construct vaccinia virus recombinants that expressed either the entire E2 coding sequence or fragments of it. These recombinants were used to immunise mice of three H-2 haplotypes to investigate their ability to elicit a neutralising antibody response against BVDV. Sera from mice immunised with the recombinant expressing full length E2 contained high levels of virus neutralising antibodies that in addition to giving neutralisation of the homologous NADL strain were also able to neutralise the Oregon C24V reference strain. These sera failed to give any neutralisation of the Osloss reference strain providing evidence for the division of BVDV isolates into at least two distinct E2 serotypes. These results were confirmed in gnotobiotic lambs. Expression of E2 fragments revealed the presence of at least two distinct neutralising epitopes, one of which was localised within the carboxy terminal 90 amino acids of the protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078593     DOI: 10.1016/s0378-1135(98)00291-0

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication.

Authors:  Young-Min Lee; Donna M Tscherne; Sang-Im Yun; Ilya Frolov; Charles M Rice
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.

Authors:  Andrea Pecora; María Sol Pérez Aguirreburualde; Alejandra Aguirreburualde; Maria Rosa Leunda; Anselmo Odeon; Sebastián Chiavenna; Diego Bochoeyer; Marcelo Spitteler; Jorge L Filippi; Maria J Dus Santos; Susana M Levy; Andrés Wigdorovitz
Journal:  Vet Res Commun       Date:  2012-05-26       Impact factor: 2.459

3.  Transdominant inhibition of bovine viral diarrhea virus entry.

Authors:  Donna M Tscherne; Matthew J Evans; Margaret R Macdonald; Charles M Rice
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by Lactobacillus casei Effectively Induces Antigen-Specific Immune Responses via Oral Vaccination.

Authors:  Yixin Wang; Baohua Feng; Chao Niu; Shuo Jia; Chao Sun; Zhuo Wang; Yanping Jiang; Wen Cui; Li Wang; Yigang Xu
Journal:  Viruses       Date:  2019-06-25       Impact factor: 5.048

Review 5.  Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis.

Authors:  Victor Riitho; Rebecca Strong; Magdalena Larska; Simon P Graham; Falko Steinbach
Journal:  Viruses       Date:  2020-10-06       Impact factor: 5.048

Review 6.  Origination and consequences of bovine viral diarrhea virus diversity.

Authors:  Steven R Bolin; Daniel L Grooms
Journal:  Vet Clin North Am Food Anim Pract       Date:  2004-03       Impact factor: 3.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.